Akynzeo IV 235 mg / 0.25 mg
Akynzeo IV 235 mg / 0.25 mg is a medicine authorised by Swissmedic under authorisation number 68290. The authorisation holder is Medius AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 September 2022 and the authorisation is limited until 31 August 2027. ATC code A04AA55 places the medicine in the group Antiemetics and antinauseants.
| Authorisation number | 68290 |
|---|---|
| Name | Akynzeo IV 235 mg / 0.25 mg |
| Full name | Akynzeo IV 235 mg / 0.25 mg, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Medius AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A04AA55 |
| First authorisation | 01 September 2022 |
| Authorisation validity | 31 August 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Akynzeo IV 235 mg / 0.25 mg, Konzentrat zur Herstellung einer Infusionslösung | B | 01 September 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | A04AA55 | 01.09.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Akynzeo IV 235 mg / 0.25 mg authorised in Switzerland?
Yes. Akynzeo IV 235 mg / 0.25 mg is authorised by Swissmedic under authorisation number 68290, data as of 01 September 2026. The authorisation is limited until 31 August 2027.
Which dispensing category does Akynzeo IV 235 mg / 0.25 mg have?
Akynzeo IV 235 mg / 0.25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Akynzeo IV 235 mg / 0.25 mg?
The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.